Key Record Dates
ClinicalTrials.gov Identifier: | NCT05727904 |
---|---|
Brief Title: | Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
First Submitted : | February 6, 2023 |
First Submitted that Met QC Criteria : | February 6, 2023 |
First Posted : | February 14, 2023 |
Last Update Submitted that Met QC Criteria : | May 13, 2024 |
Last Update Posted : | May 15, 2024 (Estimate) |